February 25, 2020 / 7:37 AM / 2 months ago

BRIEF-ISR HBV Investigates Program For Coronavirus

Feb 25 (Reuters) - ISR Immune System Regulation Holding AB (publ):

* SAID ON MONDAY UNIT ISR HBV BROADENS ITS DEVELOPMENT PORTFOLIO BY INCLUDING CORONAVIRUS AS POSSIBLE CANDIDATE FOR TREATMENT WITH CO’S IMMUNOLID ISR50

Source text for Eikon:

Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below